Member Info for Ctw2014

Great interview out this morning on total market solutions.

Shorters doing what shorters do possibly. Let them burn.

If they can’t meet debts as they fall due it will presumably be put into the hands of administrators to wind it up.

What a mess.

Best and most encouraging interview to date in my view.

Big sells earlier, that’s why. Profit taking.

It was actually March they said the results would be out, not May. I am not reading too much into the delay either way.

Whilst I wholeheartedly agree with the comments about GB (and feel that the former Finance director must also bear significant responsibility for the mess we are in) I do not believe the company is at the final curtain. With the revenue the company has in fact generated (as opposed to the inflated projections now dramatically scaled back) there ought to be a viable business here. In my view the signs are that the current board is in the process of taking the tough decisions required to turn a ridiculously over committed loss making mess into a disciplined and realistically scaled business with a reasonable chance of actually delivering some profit, if only it can successfully navigate the undoubtedly difficult immediate future. The key to that, at least so far as the interests of current shareholders are concerned (which ought to be the company’s main priority ) is to obtain whatever funding is needed to navigate that period without raising at a discount to the already hammered share price. There is sweet fa left of my £10k plus investment here (and I am sure others are showing an even bigger loss) but at least the downside risk to my investment is now minimal, so I will put these in the bottom draw and hope for some sort of recovery, if I live that long!

Market cap currently less than cash in the bank.

Took advantage of this overdone drop to top up. GLA.

44% down. Let’s see where it closes

Just topped up. One of the safest and best bets on AIM in my humble opinion, but please do your own research before investing.

Going to be a long road to a recovery here but at least some tough action is being taken to get us there.

In the interests of accuracy, we had a trading update on 16 Feb 2023, and have had two quite positive RNSs since. There is much we would all no doubt like more information on, and progress on previously announced contracts has undoubtedly been a lot slower than anticipated, but let’s not exaggerate.

Ok, more or less as predicted for 2022. Outlook for 2023 seems close to being on track albeit that the £14m run rate may not quite be achieved in H1. Despite the continuing element of jam tomorrow, I am reasonably comfortable with the outlook. Costs down, sufficient resources to maintain operations for at least the next 12 months, and at least break even expected for H1 2023; and profitability soon thereafter. Notable that Middle East volumes for Q1 2023 match those for the whole of 2022. Lots of references to near term news. Let’s see.

I am not panicking yet, given the recent further support from Sea Pearl. The delay is frustrating but i still have confidence this will come good and that patience will be rewarded. Just my opinion of course, and each to their own.

Yes, despite the negativity expressed by some (and I do understand the frustrations) in my mind this is a pretty safe bet to do very well this year, although obviously that’s just my opinion and DYOR etc.

Yep, £10,297 invested, now worth £297 if sold, over 97% down. Takes some doing that.

Yourgene Health have put out a trading update today in which they say that their audited results will be announced later than previous years due to a longer audit cycle resulting from regulatory and resourcing challenges in the audit market. It could be that those same challenges are causing the delay here. This is not the only company that is a bit late in publishing audited accounts.

Yourgene Health have just put out a trading update in which they say that their audited results for the year ended 31st March 2023 will be announced later than previous years, due to a longer audit cycle as a result of regulatory and resourcing challenges in the audit market.
It’s possible that such challenges are also causing the delay here.